THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Scott Lassman

Does a drug firm's free lunch influence doctors?

By Scott Lassman
May 18, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

JUST WHAT is the best and most appropriate way for a company that researches and manufactures a prescription medicine to educate physicians about the products it develops? It's a question that is increasingly being discussed in academic and political circles, yet too often those leading the discussions know little about the pharmaceutical industry's commitment to patient education. (Full article: 785 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass